慢性暴露促进了老鼠大脑中α-synuclein,tau和β-amyloid的聚合
O R Folarin1, F E Olopade2, T T Gilbert3
1Department of Biomedical Laboratory Science, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Journal of neurochemistry
|May 16, 2025
概括
在小鼠中长时间暴露于会导致与阿尔茨海默氏症和帕金森病相关的大脑蛋白质积聚. 这些有毒性变化,包括α-synuclein和β-amyloid聚合,在放弃了后减少了.
科学领域:
- 神经科学是一个神经科学.
- 毒理学 毒理学 毒理学
- 环境健康 环境健康
背景情况:
- 有毒金属可以通过形成蛋白质聚合物引起神经退行性疾病.
- 暴露于与神经问题有关,包括认知衰退和神经退行.
研究的目的:
- 调查长时间暴露于是否是阿尔茨海默氏症和帕金森病的危险因素.
- 为了研究对关键的神经退行性蛋白质的影响:α-synuclein (α-syn),β-amyloid (Aβ) 和tau.
主要方法:
- 通过腹腔内注射,小鼠在6,12或18个月内暴露于.
- 使用免疫光检测蛋白质聚合和细胞变化,分析了大脑组织.
- 研究了戒断组,以评估影响的可逆性.
主要成果:
- 暴露于导致特定大脑区域的α-syn,Aβ和tau蛋白的病态聚合.
- 观察到神经元退化,化和质细胞的激活.
- 在撤销瓦纳后,蛋白质病变和细胞变化减少了,但效应仍然存在.
结论:
- 长时间暴露于会促进神经退行相关蛋白质的异常积累.
- 这些蛋白质病变因老化和长时间暴露于而加剧.
- 暴露于可能是神经退行性疾病 (如阿尔茨海默氏症和帕金森病) 的危险因素.
更多相关视频
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
7.5K
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
5.8K
相关概念视频
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
